Occupe actuellement un poste chez Onconova Therapeutics Inc
Position | Company | Period |
---|---|---|
Vice President, Corporate Development and General Counsel | Onconova Therapeutics Inc | 10 décembre 2018 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2022-01-18 | 2022-01-14 |
Onconova Therapeutics Inc
(ONTX)
|
AP Achat planifié |
1 500
+7.5%
2,203 300 USD |
1 500 +7.5% | 2,20 | 3 300 USD | |
2022-01-10 | 2022-01-07 |
Onconova Therapeutics Inc
(ONTX)
|
AP Achat planifié |
1 500
+8.1%
2,393 585 USD |
1 500 +8.1% | 2,39 | 3 585 USD | |
2021-11-23 | 2021-11-19 |
Onconova Therapeutics Inc
(ONTX)
|
A Achat |
1 000
+5.7%
3,163 160 USD |
1 000 +5.7% | 3,16 | 3 160 USD | |
2021-09-29 | 2021-09-28 |
Onconova Therapeutics Inc
(ONTX)
|
A Achat |
2 381
+23.5%
4,2010 000 USD |
2 381 +23.5% | 4,20 | 10 000 USD | |
2021-02-17 | 2021-02-16 |
Onconova Therapeutics Inc
(ONTX)
|
A Achat |
12 000
+8.6%
1,0012 000 USD |
12 000 +8.6% | 1,00 | 12 000 USD | |
2020-12-14 | 2020-12-11 |
Onconova Therapeutics Inc
(ONTX)
|
A Achat |
30 000
+27.3%
0,329 600 USD |
30 000 +27.3% | 0,32 | 9 600 USD | |
2020-11-30 | 2020-11-25 |
Onconova Therapeutics Inc
(ONTX)
|
A Achat |
20 000
+22.2%
0,265 120 USD |
20 000 +22.2% | 0,26 | 5 120 USD | |
2020-05-20 | 2020-05-19 |
Onconova Therapeutics Inc
(ONTX)
|
A Achat |
15 000
+20.0%
0,375 550 USD |
15 000 +20.0% | 0,37 | 5 550 USD |